Amgen - Media - In the News

print
mail

Overview

Fact Sheets

Featured Content

Press Releases

Social Media

Media Contacts

Virtual Press Kits

In the News

Corporate News


Jan. 3, 2011	Amgen Submits Comments on the Approval Pathway for Biosimilars
Nov. 3, 2010	Amgen Provides Testimony at FDA Hearing on Biosimilars
Oct. 25, 2010	Amgen Statement on Puerto Rico Tax Legislation

Enbrel® (etanercept) in the News


Apr. 24, 2009	Amgen and Wyeth announce ENBREL Support� Program
Mar.18, 2009	Amgen Statement on Alzheimer's Case Study
Sept. 4, 2008	Amgen and Wyeth Statement on the FDA Safety Announcement Regarding Tumor Necrosis Factor (TNF) Blockers

Background Documents

Prescribing information for Enbrel®

ESAs in the News


Sep. 01, 2011	Amgen Statement on Proposed Changes to the Quality Incentive Program in Dialysis
Jun. 24, 2011	Amgen Posts Modified ESA Labeling
Jan. 19, 2011	Amgen Presents at MEDCAC Meeting on ESAs in Chronic Kidney Disease

Background Documents

Prescribing information for Aranesp®

Prescribing information for EPOGEN®

Pipeline in the News


Nov. 26, 2010	Amgen Statement on Briefing Materials Prepared for November 30, 2010 Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee Meeting
Oct. 28, 2010	Amgen to Participate in Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee
Jun. 4, 2010	Amgen at ASCO 2010

Prolia� (denosumab) in the News

Sep. 19, 2011	Press Release: FDA Approves New Indications for Prolia® (denosumab) for the Treatment of Bone Loss in Patients with Prostate or Breast Cancer Undergoing Hormone Ablation Therapy
Sep. 19, 2011	Amgen Modifies U.S. Prescribing Information for Prolia® (denosumab)
Sep. 19, 2011	Amgen Modifies Prolia® Risk Evaluation and Mitigation Strategy (REMS) Materials (US)

Background Documents

Prescribing information for Prolia®

Neulasta® (pegfilgrastim) in the News


June 19, 2009	Amgen Introduces Neulasta FIRST STEP� Program

Background Documents

Prescribing information for Neulasta®

Nplate® (romiplostim) in the News


Dec. 6, 2011	Amgen and FDA Agree to Modify Nplate® Risk Evaluation and Mitigation Strategy

Jul. 27, 2011	Amgen Modifies U.S. Prescribing Information for Nplate® (romiplostim)

Background Documents

Prescribing information for Nplate®

Vectibix® (panitumumab) in the News


Jan. 12, 2012	Amgen Modifies U.S. Prescribing Information for Vectibix® (panitumumab)
Feb. 4, 2011	Amgen Statement on Briefing Materials Prepared for February 8, 2011 Oncologic Drugs Advisory Committee Meeting
Jan. 6, 2011	Amgen to Participate in the February 8, 2011 Oncologic Drugs Advisory Committee (ODAC) Meeting on the Status of Accelerated Approvals

Background Documents

Prescribing information for Vectibix®

XGEVA� (denosumab) in the News


Nov. 18, 2010	FDA Approves Amgen's XGEVA� (denosumab) for the Prevention of Skeletal-Related Events in Patients with Bone Metastases from Solid Tumors

Background Documents

Prescribing Information for XGEVA� (denosumab) (US)

footer